Illumina, Inc. (ILMN) Stock Investment Calculator & Historical Return Analysis
Illumina, Inc. is an American biotechnology company that specializes in developing, manufacturing, and marketing integrated systems for the analysis of genetic variation and biological function. It operates primarily in the life sciences tools and services sector, focusing on genomic sequencing and array-based solutions that are utilized by a wide range of academic, government, pharmaceutical, biotechnology, and clinical institutions globally. Investors often view Illumina, Inc. as a key player in the market, analyzing its long-term potential through various revenue models, brand recognition, and consistent presence in its industry.
This Illumina, Inc. stock investment calculator allows you to explore how a hypothetical investment in ILMN might have performed over time. By adjusting the investment amount and time period, you can visualize potential growth, compare outcomes across different market cycles, and better understand the impact of long-term investing.
What if you invested $1000 in ILMN on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Understanding Illumina, Inc.'s Historical Performance
Illumina, Inc.'s stock performance has historically reflected both broader market trends and company-specific milestones. Like many growth-oriented stocks, ILMN has experienced periods of growth driven by innovation and market demand.
When analyzing Illumina, Inc.'s historical returns, it's important to consider:
- Market cycles: Strong bull markets often amplify returns, while recessions can temporarily suppress performance.
- Business model evolution: Changes in revenue strategies and product lines can significantly impact stability.
- Long-term trends: Over extended periods, compounding can play a larger role than short-term price fluctuations. Try our calculator to explore returns over 5 years or larger investments over 10 years.
This calculator helps you see how these factors might have affected an investment depending on when you entered the market.
Historical Annual Returns
Over the past 26 years, Illumina, Inc. has delivered an average annual return of 22.8%. The stock peaked in 2006 with a massive +165.4% gain, while investors faced a downturn in 2002 (-70.0%). Overall, the stock finished in the green 17 times out of 26 years.
Avg Return
+22.8%
Win Rate
65%
17W - 9L
Best
+165.4%
2006
Worst
-70.0%
2002
Performance Consistency
Illumina, Inc. Annual Returns by Year
| Year | Annual Return | Start Price | End Price |
|---|---|---|---|
| 2000 | -58.99% | $19.05 | $7.81 |
| 2001 | -22.89% | $7.42 | $5.72 |
| 2002 | -70.04% | $5.47 | $1.64 |
| 2003 | +114.94% | $1.60 | $3.43 |
| 2004 | +34.09% | $3.44 | $4.61 |
| 2005 | +52.10% | $4.51 | $6.86 |
| 2006 | +165.43% | $7.20 | $19.12 |
| 2007 | +54.28% | $18.68 | $28.82 |
| 2008 | -12.53% | $28.97 | $25.34 |
| 2009 | +14.26% | $26.12 | $29.84 |
| 2010 | +107.33% | $29.72 | $61.61 |
| 2011 | -52.63% | $62.59 | $29.65 |
| 2012 | +75.20% | $30.87 | $54.08 |
| 2013 | +99.55% | $53.91 | $107.58 |
| 2014 | +67.28% | $107.33 | $179.55 |
| 2015 | +3.52% | $180.37 | $186.72 |
| 2016 | -29.37% | $176.34 | $124.55 |
| 2017 | +66.62% | $127.56 | $212.54 |
| 2018 | +33.88% | $217.93 | $291.76 |
| 2019 | +12.64% | $286.50 | $322.70 |
| 2020 | +13.15% | $318.09 | $359.92 |
| 2021 | +3.45% | $357.74 | $370.08 |
| 2022 | -46.91% | $370.50 | $196.69 |
| 2023 | -30.68% | $195.40 | $135.45 |
| 2024 | -0.17% | $133.86 | $133.63 |
| 2025 | +0.18% | $130.93 | $131.16 |
Historical annual returns for Illumina, Inc.. Data shows year-over-year percentage change in stock price.
Why Use a "What If" Stock Calculator?
Many investors wonder questions such as:
- What if I had invested 5 years ago?
- How does timing affect long-term returns?
- What role does compounding play in stock investments?
A what-if investment calculator answers these questions by turning historical data into practical insights. Rather than focusing on daily price movements, it encourages a long-term perspective, which is especially useful for retirement planning, portfolio comparisons, and financial education.
Key Innovations
- ✓Pioneering and continuously advancing DNA Sequencing Platforms (e.g., NovaSeq, HiSeq, MiSeq, MiniSeq, iSeq, NextSeq) utilizing sophisticated technologies like bridge amplification and reversible terminators.
- ✓Introduction of the NovaSeq X Plus in September 2022, a high-throughput sequencing system capable of sequencing up to 20,000 genomes per year.
- ✓Development of a comprehensive bioinformatics suite and software solutions that facilitate the analysis and interpretation of vast amounts of genetic data.
- ✓Maintaining a dominant position in the genomics market, driven by its next-generation sequencing (NGS) technology.
Business Segments
- Genomic SequencingProvides DNA sequencing platforms and consumables for various applications, including whole-genome sequencing, targeted sequencing, and RNA sequencing.
- Microarray SolutionsOffers microarrays for SNP genotyping, gene expression, and protein analysis, providing a cost-effective way to analyze genetic markers.
- Kits and ReagentsDevelops and supplies a comprehensive range of kits and reagents, including library preparation kits, for diverse DNA and RNA inquiries.
How to Interpret the Results
The results shown are based on historical performance and are meant for educational and informational purposes only. They do not account for future market conditions, taxes, transaction fees, or individual investment strategies. Past performance does not guarantee future results, but historical analysis can help investors understand risk, volatility, and growth potential.
For best use:
- Compare multiple time ranges to see how outcomes differ
- Use consistent assumptions across different stocks
- Combine this tool with fundamental research and diversification principles